ADHD Diagnosis

Valerie Vaz Excerpts

Tuesday 20th January 2026 Westminster Hall

[Several hon. Members rose—]

[Valerie Vaz (in the Chair)]

I ask hon. Members to remain standing. I will call the Front-Benchers at 5.23 pm. I am afraid I am going to impose a two-minute time limit, but you can do it as Olivia Dean says, by being “nice to each other”, or I can put impose a hard limit. We will start with the soft two-minute limit. I call Rachael Maskell.

--- Later in debate ---

[Valerie Vaz (in the Chair)]

I now have to impose a hard two-minute limit.

[Andrew Cooper (Mid Cheshire) (Lab)]

It is a pleasure to serve under your chairmanship, Ms Vaz. I congratulate my hon. Friend the Member for Sefton Central (Bill Esterson) on securing this debate. He knows my links to his constituency, and I am certain that his moving tribute to Matt will be appreciated by Matt’s family, his Labour family and everybody that knew and loved him.

ADHD affects people of all ages, backgrounds and communities, yet too many are stuck on waiting lists for years, during which time their needs go unmet and their wellbeing deteriorates. In the limited time I have, I want to make three points. First, on barriers and gatekeeping, I have received so many cases of schools refusing or postponing referrals, adults reporting GPs minimising symptoms, and community paediatrics increasingly rejecting referrals even when evidence is clear or a private diagnosis exists. Such gatekeeping practices do not protect services; they merely protect delay and lead to wider mental health problems in the long term.

Secondly, on the right to choose, I am sure we all have cases in our mailbags where constituents have been forced to obtain a private diagnosis because of waiting list delays, only to find that the NHS rejects the assessment, will not provide the medication they need or will not play fair on the shared care agreement. That is wholly improper.

Thirdly, I assisted an individual whose referral to adult services was not made before community paediatrics stopped prescribing as he transitioned from childhood to adulthood. Due to excessive waiting lists, this person has been without ADHD medication since March 2025, which is indicative of a system that is not working properly. Will the Minister address the systemic barriers to the ADHD pathway?

[Valerie Vaz (in the Chair)]

Order. I am so sorry.

--- Later in debate ---

[Several hon. Members rose—]

[Valerie Vaz (in the Chair)]

Getting in the two remaining speakers will squeeze the wind-ups. Mr Esterson, you had a fair bit to start with. Maybe the Front Benchers could not use their full time.

[Sarah Hall (Warrington South) (Lab/Co-op)]

Thank you, Ms Vaz, it is a pleasure to serve under your chairship. Too many people in Warrington South are being failed by the system that is meant to help them. Demand for ADHD assessments has risen sharply, with waits of up to six years. As someone whose ADHD was diagnosed when I was an adult, I know at first hand how difficult it can be to navigate a system that often does not join up or listen properly.

Ahead of this debate, I asked constituents to share their experiences of seeking an ADHD diagnosis. Adults told me that they waited years for assessment, only to be pushed through mental health pathways that did not fit and prescribed medication that made things worse. While waiting, some self-medicated with alcohol or drugs, not to escape but simply to cope. Years of masking, burnout and misdiagnosis have taken their toll. Parents told me that their children were identified early in nursery or reception, but support stalled because schools are restricted in what they can do without a diagnosis. By the time the referrals are finally made, children are already struggling, falling behind or believing they are lazy or stupid.

I heard from women diagnosed in their 40s, 50s and 60s, after a lifetime of being treated for anxiety or depression that never quite made sense. Teachers contacted me too—experienced, committed professionals who want to help but are trying to meet complex needs in classes of 30 or more children, with limited support and resources. They told me that diagnosis means very little if there is no capacity to act on it. In Warrington, concerns about waiting times came up again and again. Misdiagnosis, problems in education, workplace breakdowns, mental health crises and families forced into private care, if they can afford it, while others are simply forced to cope until they cannot cope any more.

When Ministers point to frameworks and data improvements, I say that those things matter but do not help the child struggling in school today or the adult in crisis being told to wait until the next decade. This is not about ADHD being over-diagnosed; it is about a system that consistently under-treats and under-supports those who have it. We desperately need more specialists, more appointments, more assessments, and waiting lists that are measured in months not years.

[Valerie Vaz (in the Chair)]

Order. I am sorry, but time is up.

[Jack Abbott (Ipswich) (Lab/Co-op)]

Thank you, Ms Vaz. I thank my hon. Friend the Member for Sefton Central (Bill Esterson) for securing this important debate. He spoke powerfully about the long and agonising waits that many people have to endure to get an ADHD diagnosis, but I want to focus on what happens next. For many people, receiving a diagnosis is not the end of the fight; in many cases, it is the start of a new one.

Time and again I hear from people who, after finally securing that elusive diagnosis, encounter a set of new barriers that prevent them from accessing the treatment they are entitled to. In January 2025, local medical committees in Suffolk and Essex advised GPs to stop delivering ADHD treatment under shared care agreements. A survey by Healthwatch Suffolk of people’s experience of the changes to shared care found that only 40% had received prescriptions or monitoring from their GP. Of those, 69% said that their GP had already stopped or would soon stop providing support.

Most received only two or three months’ notice that their shared care agreement was ending; some had no notice at all. Patients are left in limbo: they have been diagnosed, and maybe even stabilised on medication, and they are suddenly told that their shared care agreement is ending. In some instances, people are left with no access to medication whatsoever. I have received letters from terrified parents and families, panic-stricken at the prospect of being left without the medicine that they need to function every day.

I look forward to hearing the Goernment’s response to the ADHD taskforce recommendations and I welcome the launch of the independent review into the prevalence of and support for mental health conditions, ADHD and autism. Reducing waiting times for an assessment and diagnosis is critical, but that work will be rendered futile if we do not also address the crisis of timely access to medication and support. For too many of my constituents—and I am sure for the constituents of many Members across the room—the hardest part of their ADHD journey did not end with diagnosis; it simply began there.

[Valerie Vaz (in the Chair)]

Thank you. All colleagues got in. I call the Liberal Democrat spokesperson, Adam Dance.

--- Later in debate ---

[Iqbal Mohamed]

Approximately a quarter of the prison population—22,000, give or take—have ADHD. Will the Government commit to an impact assessment of what savings the Government could make, and how many people’s lives could be improved, by assessing people either before they commit a crime or after?

[Valerie Vaz (in the Chair)]

Order. The Minister knows that he has two minutes.

[Dr Ahmed]

As the hon. Gentleman will know, I have a lot of things in my purview, but prisons are not one of them. However, his point is well made. We expect that such sub-groups would be investigated and interrogated during the prevalence review.

I do have only two minutes, Ms Vaz, so I will move on quickly and not test your patience. In the longer term, we recognise the need to understand the factors behind the rising demand for services. We recognise that ADHD and autism frequently co-occur, which is why it will be important for the prevalence review to look at the conditions holistically as well as individually.

I acknowledge the impact that delays in accessing assessments and diagnosis are having on people, and I thank my hon. Friend the Member for Sefton Central for tabling this important and timely debate. I hope that the actions I have set out today, including the prevalence review and how it will dovetail with other reviews and other Departments, will provide some reassurance to my hon. Friend and other colleagues that we are taking these matters extremely seriously, and with a parity of esteem with any physical health condition or issue. I hope that all hon. Members’ constituents start to feel that progress very soon.

[Valerie Vaz (in the Chair)]

Bill Esterson, you have a few seconds to wind up.